ArticleJournal of hematology & oncology2020
GD2 or HER2 targeting T cell engaging bispecific antibodies to treat osteosarcoma.
Jeong A Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
62 papers cite itlatest 60 shown
this paperpooled itcites it